C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias

NCT04786223 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2

Investigation of Inflammation Using [C-11]-CS1P1

NCT04517552 ·Status: ACTIVE_NOT_RECRUITING

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI

NCT05615415 ·Status: ACTIVE_NOT_RECRUITING

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

NCT03759522 ·Status: RECRUITING ·Phase: PHASE1

Zooming in on Cerebral Abnormalities in Severely Affected COVID-19 Patients

NCT05197296 ·Status: UNKNOWN

11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation

NCT02811744 ·Status: TERMINATED ·Phase: PHASE2

[18F]MC225-PET in Neurodegenerative Disease

NCT05853471 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis

NCT01651520 ·Status: UNKNOWN ·Phase: NA

PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram

NCT00250172 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand 11C-MK-3168 and the Blocking of the Retention of the Ligand in the Human Brain by JNJ-42165279

NCT02169973 ·Status: COMPLETED ·Phase: PHASE1

Molecular Imaging of NET Using [C-11]MRB-PET in MS

NCT03207464 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants

NCT05320302 ·Status: COMPLETED ·Phase: PHASE1

This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.

NCT07115017 ·Status: RECRUITING

Normal Binding of R-[11C]PK11195 in Human Subjects

NCT00205595 ·Status: UNKNOWN ·Phase: PHASE1

Neuroinflammation Imaging in AD

NCT04274998 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Molecular Imaging of Plaque Vulnerability

NCT02640313 ·Status: RECRUITING ·Phase: PHASE3

[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)

NCT02562989 ·Status: COMPLETED ·Phase: PHASE1

Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD

NCT07115238 ·Status: RECRUITING ·Phase: PHASE3

Translocator Protein and Inflammation After Traumatic Brain Injury

NCT01547780 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

TSPO-PET/MRI in Surveillance of Neuroinflammation in the Central Nervous System

NCT06467773 ·Status: RECRUITING

Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

NCT01209156 ·Status: COMPLETED ·Phase: PHASE1

Study of Neurological Damage From Coronavirus Disease (COVID-19)

NCT05079373 ·Status: UNKNOWN

Long-term Effects of SARS-CoV-2 on the Central Nervous System and One-year Follow-up of "Long COVID-19" Patients

NCT05492292 ·Status: UNKNOWN ·Phase: NA

Brain Imaging in the Diabetes Prevention Program Outcomes Study

NCT03757910 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Pilot PET Study of Regional Cerebral Protein Synthesis in Alzheimer's

NCT05491902 ·Status: TERMINATED